![]() ![]() Microbac Lab tested the wipes in compliance with EPA Product Performance Test Guideline OCSPP 810.2200: Disinfectants for Use on Environmental Surfaces, Guidance for Efficacy Testing. Receiving EPA claim approval provides assurance to our customers that Super Sani-Cloth wipes are effective against the SARS-CoV-2 virus." "Our layered approach to infection prevention enables our customer to have a robust portfolio of high quality solutions to avoid healthcare acquired infections. "As a leader in infection prevention, we are committed to help protect patients, caregivers and communities," said Sean Gallimore, Senior Vice President and General Manager of PDI Healthcare. Prior to receiving approval for this claim, Super Sani-Cloth wipes were included on EPA's List N entitled "Disinfectants for Use Against SARS-CoV-2." According to the data provided by PDI Healthcare, the Super Sani-Cloth wipes caused a 3-log reduction against the SARS-CoV-2 virus, which meets the EPA's efficacy requirements. Before a product can legally make efficacy claims against a particular pathogen, the claim must be approved by the EPA based on a thorough review of scientific data. 9480-4) to include deactivation of SARS-CoV-2, the virus that causes COVID-19, after one minute of contact time on hard, nonporous surfaces. The EPA approval expanded the label claims for Super Sani-Cloth wipes (EPA Reg No. Super Sani-Cloth Wipes receive EPA approval for SARS-CoV-2 claim ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |